Rybelsus 7 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRQY9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,880
Award facts
- Contract value 100% obligated
- $12,879.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $12,879.95 and an ultimate completion date of July 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in that same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
This delivery order represents a routine pharmaceutical supply transaction within the scope of AmerisourceBergen's existing prime contract vehicle, which provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Rybelsus, a diabetes medication, falls within the company's established portfolio of therapeutic medications supplied to federal customers including the Defense Health Agency and U.S. Coast Guard. As a non-set-aside award, this order reflects AmerisourceBergen's continued capability to meet federal procurement requirements through competitive processes and its role as a critical vendor in the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FRQY9?
SPE2DB25FRQY9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FRQY9 worth?
The government has obligated $12,880 on SPE2DB25FRQY9.
Is contract SPE2DB25FRQY9 an order under another contract?
Yes. SPE2DB25FRQY9 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRQY9 competed?
The extent of competition for SPE2DB25FRQY9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award